

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 8.06832405 |
| 2 | central nervous system myelination (GO:0022010) | 8.06832405 |
| 3 | hemidesmosome assembly (GO:0031581) | 7.39832855 |
| 4 | desmosome organization (GO:0002934) | 5.99832523 |
| 5 | fatty acid elongation (GO:0030497) | 4.92648771 |
| 6 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.49749891 |
| 7 | photoreceptor cell differentiation (GO:0046530) | 4.38695303 |
| 8 | eye photoreceptor cell differentiation (GO:0001754) | 4.38695303 |
| 9 | COPII vesicle coating (GO:0048208) | 4.37799018 |
| 10 | ensheathment of neurons (GO:0007272) | 4.35170522 |
| 11 | axon ensheathment (GO:0008366) | 4.35170522 |
| 12 | myelination (GO:0042552) | 4.31327188 |
| 13 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.10336510 |
| 14 | cell adhesion mediated by integrin (GO:0033627) | 4.10327656 |
| 15 | skin morphogenesis (GO:0043589) | 4.09496546 |
| 16 | establishment of mitochondrion localization (GO:0051654) | 4.04126870 |
| 17 | negative regulation of neurotransmitter transport (GO:0051589) | 4.02407858 |
| 18 | myelin maintenance (GO:0043217) | 3.99936821 |
| 19 | sensory perception of smell (GO:0007608) | 3.98268224 |
| 20 | glycerophospholipid catabolic process (GO:0046475) | 3.92535999 |
| 21 | collagen fibril organization (GO:0030199) | 3.91569902 |
| 22 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.90381504 |
| 23 | melanin biosynthetic process (GO:0042438) | 3.81578541 |
| 24 | establishment of skin barrier (GO:0061436) | 3.72309109 |
| 25 | endodermal cell differentiation (GO:0035987) | 3.69873580 |
| 26 | COPI coating of Golgi vesicle (GO:0048205) | 3.61745105 |
| 27 | Golgi transport vesicle coating (GO:0048200) | 3.61745105 |
| 28 | cell-substrate junction assembly (GO:0007044) | 3.60436130 |
| 29 | regulation of water loss via skin (GO:0033561) | 3.54995149 |
| 30 | keratinocyte proliferation (GO:0043616) | 3.54990313 |
| 31 | melanin metabolic process (GO:0006582) | 3.53969972 |
| 32 | negative regulation of protein localization to cell surface (GO:2000009) | 3.46908869 |
| 33 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.46166973 |
| 34 | apical protein localization (GO:0045176) | 3.44467836 |
| 35 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.41305912 |
| 36 | cholesterol biosynthetic process (GO:0006695) | 3.38506922 |
| 37 | asymmetric protein localization (GO:0008105) | 3.34002382 |
| 38 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.33312877 |
| 39 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.28950744 |
| 40 | chondrocyte proliferation (GO:0035988) | 3.25819646 |
| 41 | response to methylmercury (GO:0051597) | 3.25565096 |
| 42 | response to redox state (GO:0051775) | 3.24218163 |
| 43 | magnesium ion transport (GO:0015693) | 3.23511471 |
| 44 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.22161117 |
| 45 | keratinization (GO:0031424) | 3.17432683 |
| 46 | sterol biosynthetic process (GO:0016126) | 3.15210322 |
| 47 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.14740491 |
| 48 | regulation of cardioblast differentiation (GO:0051890) | 3.14122181 |
| 49 | protein polyglutamylation (GO:0018095) | 3.12447995 |
| 50 | keratan sulfate catabolic process (GO:0042340) | 3.11220497 |
| 51 | amyloid precursor protein metabolic process (GO:0042982) | 3.10255392 |
| 52 | basement membrane organization (GO:0071711) | 3.10057326 |
| 53 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.08616479 |
| 54 | secondary metabolite biosynthetic process (GO:0044550) | 3.06966857 |
| 55 | glomerular basement membrane development (GO:0032836) | 3.06362477 |
| 56 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.02232128 |
| 57 | kidney mesenchyme development (GO:0072074) | 3.01942854 |
| 58 | apoptotic cell clearance (GO:0043277) | 2.97665672 |
| 59 | protein retention in ER lumen (GO:0006621) | 2.97310855 |
| 60 | regulation of collateral sprouting (GO:0048670) | 2.96722433 |
| 61 | cellular potassium ion homeostasis (GO:0030007) | 2.94345665 |
| 62 | neuronal action potential propagation (GO:0019227) | 2.93753921 |
| 63 | cell migration involved in heart development (GO:0060973) | 2.93601971 |
| 64 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.92773233 |
| 65 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.92278823 |
| 66 | collagen metabolic process (GO:0032963) | 2.90735390 |
| 67 | chondrocyte development (GO:0002063) | 2.89090470 |
| 68 | response to pheromone (GO:0019236) | 2.89002660 |
| 69 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.88943131 |
| 70 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.86546633 |
| 71 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.85861230 |
| 72 | extracellular matrix disassembly (GO:0022617) | 2.84596763 |
| 73 | regulation of keratinocyte proliferation (GO:0010837) | 2.84207704 |
| 74 | synaptic vesicle maturation (GO:0016188) | 2.83987168 |
| 75 | collagen catabolic process (GO:0030574) | 2.83217804 |
| 76 | dopamine biosynthetic process (GO:0042416) | 2.81514871 |
| 77 | potassium ion import (GO:0010107) | 2.78829392 |
| 78 | creatine metabolic process (GO:0006600) | 2.78772397 |
| 79 | polarized epithelial cell differentiation (GO:0030859) | 2.77798610 |
| 80 | substantia nigra development (GO:0021762) | 2.77797220 |
| 81 | potassium ion homeostasis (GO:0055075) | 2.77105621 |
| 82 | metanephric mesenchyme development (GO:0072075) | 2.76671437 |
| 83 | multicellular organismal catabolic process (GO:0044243) | 2.76659349 |
| 84 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.76427146 |
| 85 | isoprenoid biosynthetic process (GO:0008299) | 2.74883969 |
| 86 | regulation of female gonad development (GO:2000194) | 2.74323558 |
| 87 | multicellular organismal metabolic process (GO:0044236) | 2.74274321 |
| 88 | barbed-end actin filament capping (GO:0051016) | 2.73821259 |
| 89 | neuron cell-cell adhesion (GO:0007158) | 2.73401918 |
| 90 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.72327771 |
| 91 | neuron remodeling (GO:0016322) | 2.71111123 |
| 92 | peptidyl-proline hydroxylation (GO:0019511) | 2.70507552 |
| 93 | regulation of lipoprotein metabolic process (GO:0050746) | 2.70484383 |
| 94 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.69814711 |
| 95 | sensory perception of chemical stimulus (GO:0007606) | 2.68735651 |
| 96 | synaptic vesicle exocytosis (GO:0016079) | 2.67907075 |
| 97 | protein localization to endosome (GO:0036010) | 2.65942708 |
| 98 | protein hydroxylation (GO:0018126) | 2.65426868 |
| 99 | gap junction assembly (GO:0016264) | 2.65272427 |
| 100 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.64088667 |
| 101 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.63381410 |
| 102 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.63381410 |
| 103 | keratinocyte differentiation (GO:0030216) | 2.63037579 |
| 104 | positive regulation of odontogenesis (GO:0042482) | 2.62530807 |
| 105 | adult walking behavior (GO:0007628) | 2.62376221 |
| 106 | smooth muscle tissue development (GO:0048745) | 2.61958131 |
| 107 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.61759754 |
| 108 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.60916287 |
| 109 | microtubule severing (GO:0051013) | 2.59574820 |
| 110 | negative regulation of catenin import into nucleus (GO:0035414) | 2.58173290 |
| 111 | vesicle coating (GO:0006901) | 2.57093299 |
| 112 | regulation of early endosome to late endosome transport (GO:2000641) | 2.56868182 |
| 113 | regulation of autophagic vacuole assembly (GO:2000785) | 2.56427992 |
| 114 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.54563914 |
| 115 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.52963991 |
| 116 | positive regulation of potassium ion transport (GO:0043268) | 2.52903550 |
| 117 | midgut development (GO:0007494) | 2.51792972 |
| 118 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.50634948 |
| 119 | protein palmitoylation (GO:0018345) | 2.50197041 |
| 120 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.49524097 |
| 121 | protein neddylation (GO:0045116) | 2.49234969 |
| 122 | endothelial cell morphogenesis (GO:0001886) | 2.48524513 |
| 123 | oligodendrocyte differentiation (GO:0048709) | 2.48084204 |
| 124 | negative regulation of fatty acid transport (GO:2000192) | 2.47380582 |
| 125 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.47046627 |
| 126 | L-amino acid import (GO:0043092) | 2.47017313 |
| 127 | negative regulation of cartilage development (GO:0061037) | 2.46993002 |
| 128 | organ induction (GO:0001759) | 2.46810526 |
| 129 | neuronal action potential (GO:0019228) | 2.46748299 |
| 130 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.46699981 |
| 131 | mitochondrion transport along microtubule (GO:0047497) | 2.46699981 |
| 132 | muscle cell cellular homeostasis (GO:0046716) | 2.46495985 |
| 133 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.43750863 |
| 134 | epidermis development (GO:0008544) | 2.43622393 |
| 135 | presynaptic membrane organization (GO:0097090) | 2.42616001 |
| 136 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.42041008 |
| 137 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.41900899 |
| 138 | neurotransmitter uptake (GO:0001504) | 2.41707932 |
| 139 | mating behavior (GO:0007617) | 2.41394974 |
| 140 | paraxial mesoderm development (GO:0048339) | 2.41362782 |
| 141 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.40029599 |
| 142 | hypotonic response (GO:0006971) | 2.39752046 |
| 143 | glutamate secretion (GO:0014047) | 2.39467838 |
| 144 | detection of temperature stimulus (GO:0016048) | 2.39241842 |
| 145 | neurofilament cytoskeleton organization (GO:0060052) | 2.37721294 |
| 146 | axonal fasciculation (GO:0007413) | 2.37558503 |
| 147 | limb bud formation (GO:0060174) | 2.37380117 |
| 148 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.36999229 |
| 149 | neuron recognition (GO:0008038) | 2.35816238 |
| 150 | regulation of chondrocyte differentiation (GO:0032330) | 2.34895281 |
| 151 | cellular response to vitamin (GO:0071295) | 2.34702420 |
| 152 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.34219355 |
| 153 | peptide cross-linking (GO:0018149) | 2.33809251 |
| 154 | renal filtration (GO:0097205) | 2.32495099 |
| 155 | extracellular fibril organization (GO:0043206) | 2.32351157 |
| 156 | extracellular structure organization (GO:0043062) | 2.32212565 |
| 157 | extracellular matrix organization (GO:0030198) | 2.32171885 |
| 158 | peptidyl-cysteine modification (GO:0018198) | 2.32017420 |
| 159 | cochlea morphogenesis (GO:0090103) | 2.31987950 |
| 160 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.31153076 |
| 161 | positive regulation of mesenchymal cell proliferation (GO:0002053) | 2.30739693 |
| 162 | wound healing, spreading of epidermal cells (GO:0035313) | 2.30249682 |
| 163 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.29508829 |
| 164 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.28191668 |
| 165 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.28028344 |
| 166 | bone trabecula formation (GO:0060346) | 2.27728165 |
| 167 | axon development (GO:0061564) | 2.27375648 |
| 168 | establishment of planar polarity (GO:0001736) | 2.25875626 |
| 169 | establishment of tissue polarity (GO:0007164) | 2.25875626 |
| 170 | enteric nervous system development (GO:0048484) | 2.25498821 |
| 171 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.25230246 |
| 172 | negative regulation of inclusion body assembly (GO:0090084) | 2.25132827 |
| 173 | positive regulation of neurological system process (GO:0031646) | 2.23821284 |
| 174 | mammary gland epithelial cell proliferation (GO:0033598) | 2.23507288 |
| 175 | ventricular cardiac muscle cell development (GO:0055015) | 2.23481311 |
| 176 | type B pancreatic cell proliferation (GO:0044342) | 2.23349363 |
| 177 | epithelial cell-cell adhesion (GO:0090136) | 2.23075743 |
| 178 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.22739265 |
| 179 | regulation of metalloenzyme activity (GO:0048552) | 2.22376655 |
| 180 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.22222276 |
| 181 | glomerular visceral epithelial cell development (GO:0072015) | 2.22131924 |
| 182 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.21681750 |
| 183 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.21620188 |
| 184 | sodium ion export (GO:0071436) | 2.21325463 |
| 185 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.21301600 |
| 186 | negative regulation of axonogenesis (GO:0050771) | 2.20910333 |
| 187 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.20883784 |
| 188 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.20450537 |
| 189 | membrane protein ectodomain proteolysis (GO:0006509) | 2.19790832 |
| 190 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.19745427 |
| 191 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.19674055 |
| 192 | cellular response to vitamin D (GO:0071305) | 2.19506662 |
| 193 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.18921792 |
| 194 | peripheral nervous system development (GO:0007422) | 2.18842359 |
| 195 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.18613449 |
| 196 | ER overload response (GO:0006983) | 2.18557319 |
| 197 | regulation of vacuole organization (GO:0044088) | 2.18426170 |
| 198 | detection of calcium ion (GO:0005513) | 2.18094624 |
| 199 | microtubule polymerization or depolymerization (GO:0031109) | 2.16286749 |
| 200 | organelle transport along microtubule (GO:0072384) | 2.16046136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.49072353 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.59576637 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.53128266 |
| 4 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.44031764 |
| 5 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.17703085 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.74666769 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.44616156 |
| 8 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.38725946 |
| 9 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.38725946 |
| 10 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.32562993 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.21115809 |
| 12 | TP53_18474530_ChIP-ChIP_U2OS_Human | 2.18287922 |
| 13 | CJUN_26792858_Chip-Seq_BT549_Human | 2.18251778 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.16773538 |
| 15 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 2.16240028 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.15838255 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.13959795 |
| 18 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.13747406 |
| 19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.10902447 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.10827483 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 2.04174000 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.03978259 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.03978259 |
| 24 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.02671251 |
| 25 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.96899755 |
| 26 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.96140301 |
| 27 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.89520367 |
| 28 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.87759101 |
| 29 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.86860506 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.85054535 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.79619184 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.78009945 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.75983167 |
| 34 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.73234916 |
| 35 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72670945 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.71588498 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.67714442 |
| 38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.67296446 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66770215 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.63527785 |
| 41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63396489 |
| 42 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.61705759 |
| 43 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58427936 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57125947 |
| 45 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.56557451 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56498483 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.55900370 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.55725420 |
| 49 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.55724869 |
| 50 | TP53_16413492_ChIP-PET_HCT116_Human | 1.53671027 |
| 51 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.53642242 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53440606 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52055764 |
| 54 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51376352 |
| 55 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.49980706 |
| 56 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49461303 |
| 57 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.48902718 |
| 58 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.48018512 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46265315 |
| 60 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45917257 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44548475 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.43484476 |
| 63 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.42488858 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39714719 |
| 65 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.38923356 |
| 66 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.38361210 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38110615 |
| 68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38105788 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37779289 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35579273 |
| 71 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.34442388 |
| 72 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.34442388 |
| 73 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.33353695 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.33162402 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32987284 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.32984772 |
| 77 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31947922 |
| 78 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.30894443 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30883425 |
| 80 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.30374490 |
| 81 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29466858 |
| 82 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29256547 |
| 83 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28758128 |
| 84 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28734857 |
| 85 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28215426 |
| 86 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.28176726 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28080411 |
| 88 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.27005561 |
| 89 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26891012 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26874509 |
| 91 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.26301318 |
| 92 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26233714 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25351327 |
| 94 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25030245 |
| 95 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.23908311 |
| 96 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.21756403 |
| 97 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.20805162 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20386392 |
| 99 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19883451 |
| 100 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19814421 |
| 101 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.19227354 |
| 102 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.18368588 |
| 103 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.17818846 |
| 104 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17738761 |
| 105 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.16830525 |
| 106 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.16663189 |
| 107 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15928223 |
| 108 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14988229 |
| 109 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13909577 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13535085 |
| 111 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.13446795 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12798019 |
| 113 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11831626 |
| 114 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11772012 |
| 115 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.11163680 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11125921 |
| 117 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10656701 |
| 118 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.09675106 |
| 119 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08873836 |
| 120 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.08818189 |
| 121 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.08508707 |
| 122 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08034352 |
| 123 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07657422 |
| 124 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.07414623 |
| 125 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07050144 |
| 126 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.06357388 |
| 127 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.05842165 |
| 128 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05581297 |
| 129 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.03637291 |
| 130 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03465683 |
| 131 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03465683 |
| 132 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03177964 |
| 133 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.02777133 |
| 134 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02670730 |
| 135 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01699945 |
| 136 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01644756 |
| 137 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01435294 |
| 138 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.99869836 |
| 139 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99408989 |
| 140 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97159002 |
| 141 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96811564 |
| 142 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96718940 |
| 143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96690602 |
| 144 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96413438 |
| 145 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.96256360 |
| 146 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96073487 |
| 147 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95918270 |
| 148 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95518982 |
| 149 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94760652 |
| 150 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.94466027 |
| 151 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.94396684 |
| 152 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93956242 |
| 153 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93956242 |
| 154 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93950496 |
| 155 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93668587 |
| 156 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92767674 |
| 157 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.92113312 |
| 158 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.91936571 |
| 159 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91757030 |
| 160 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90811075 |
| 161 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90017713 |
| 162 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89767587 |
| 163 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.89546303 |
| 164 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88907905 |
| 165 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88907905 |
| 166 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.88600612 |
| 167 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.88599971 |
| 168 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88158774 |
| 169 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87292917 |
| 170 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.86944551 |
| 171 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.84513441 |
| 172 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84109413 |
| 173 | ATF3_27146783_Chip-Seq_COLON_Human | 0.83338328 |
| 174 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83265186 |
| 175 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81524597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.53553163 |
| 2 | MP0005275_abnormal_skin_tensile | 4.89247712 |
| 3 | MP0004270_analgesia | 4.04882514 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.68066829 |
| 5 | MP0005257_abnormal_intraocular_pressure | 3.36553500 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.09107642 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.05777043 |
| 8 | MP0004272_abnormal_basement_membrane | 3.02860168 |
| 9 | MP0000920_abnormal_myelination | 2.84933605 |
| 10 | MP0003941_abnormal_skin_development | 2.84155548 |
| 11 | MP0003880_abnormal_central_pattern | 2.80387207 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.61719753 |
| 13 | MP0001485_abnormal_pinna_reflex | 2.52634065 |
| 14 | MP0003329_amyloid_beta_deposits | 2.41437980 |
| 15 | MP0002272_abnormal_nervous_system | 2.41284341 |
| 16 | MP0005408_hypopigmentation | 2.40833302 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.40730077 |
| 18 | MP0002060_abnormal_skin_morphology | 2.24837882 |
| 19 | MP0004885_abnormal_endolymph | 2.22549203 |
| 20 | MP0004145_abnormal_muscle_electrophysio | 2.21851376 |
| 21 | MP0000372_irregular_coat_pigmentation | 2.21753579 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.19797710 |
| 23 | MP0004043_abnormal_pH_regulation | 2.16554921 |
| 24 | MP0003566_abnormal_cell_adhesion | 2.09481368 |
| 25 | MP0003950_abnormal_plasma_membrane | 2.06406429 |
| 26 | MP0001984_abnormal_olfaction | 2.06201653 |
| 27 | MP0004859_abnormal_synaptic_plasticity | 2.06157720 |
| 28 | MP0001529_abnormal_vocalization | 2.03363546 |
| 29 | MP0000462_abnormal_digestive_system | 2.03119336 |
| 30 | MP0001905_abnormal_dopamine_level | 2.01076990 |
| 31 | MP0001486_abnormal_startle_reflex | 1.96940934 |
| 32 | MP0004134_abnormal_chest_morphology | 1.89360806 |
| 33 | MP0004742_abnormal_vestibular_system | 1.86976075 |
| 34 | MP0002796_impaired_skin_barrier | 1.84771491 |
| 35 | MP0001958_emphysema | 1.83225932 |
| 36 | MP0003635_abnormal_synaptic_transmissio | 1.75819903 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.75788549 |
| 38 | MP0002735_abnormal_chemical_nociception | 1.74828103 |
| 39 | MP0005409_darkened_coat_color | 1.74390202 |
| 40 | MP0006054_spinal_hemorrhage | 1.68488425 |
| 41 | MP0003646_muscle_fatigue | 1.68368477 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.67636978 |
| 43 | MP0000778_abnormal_nervous_system | 1.66338879 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.66024411 |
| 45 | MP0002064_seizures | 1.62992145 |
| 46 | MP0001970_abnormal_pain_threshold | 1.62652179 |
| 47 | MP0002229_neurodegeneration | 1.62358927 |
| 48 | MP0001963_abnormal_hearing_physiology | 1.61897813 |
| 49 | MP0000015_abnormal_ear_pigmentation | 1.60587107 |
| 50 | MP0004142_abnormal_muscle_tone | 1.60516082 |
| 51 | MP0001968_abnormal_touch/_nociception | 1.59376658 |
| 52 | MP0003279_aneurysm | 1.59077594 |
| 53 | MP0002184_abnormal_innervation | 1.58969375 |
| 54 | MP0000751_myopathy | 1.58620505 |
| 55 | MP0002733_abnormal_thermal_nociception | 1.58503921 |
| 56 | MP0002896_abnormal_bone_mineralization | 1.56327123 |
| 57 | MP0009053_abnormal_anal_canal | 1.56101751 |
| 58 | MP0003634_abnormal_glial_cell | 1.55731683 |
| 59 | MP0001299_abnormal_eye_distance/ | 1.55005142 |
| 60 | MP0000747_muscle_weakness | 1.52878688 |
| 61 | MP0006276_abnormal_autonomic_nervous | 1.51599731 |
| 62 | MP0005023_abnormal_wound_healing | 1.50543022 |
| 63 | MP0000955_abnormal_spinal_cord | 1.50007115 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.49197769 |
| 65 | MP0003879_abnormal_hair_cell | 1.48814215 |
| 66 | MP0000013_abnormal_adipose_tissue | 1.47424732 |
| 67 | MP0004036_abnormal_muscle_relaxation | 1.45688443 |
| 68 | MP0001661_extended_life_span | 1.43010478 |
| 69 | MP0005248_abnormal_Harderian_gland | 1.41672910 |
| 70 | MP0003136_yellow_coat_color | 1.39384721 |
| 71 | MP0005508_abnormal_skeleton_morphology | 1.37892126 |
| 72 | MP0005646_abnormal_pituitary_gland | 1.35375174 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.35201243 |
| 74 | MP0010030_abnormal_orbit_morphology | 1.33503296 |
| 75 | MP0002067_abnormal_sensory_capabilities | 1.33122025 |
| 76 | MP0002736_abnormal_nociception_after | 1.32702609 |
| 77 | MP0000749_muscle_degeneration | 1.29898130 |
| 78 | MP0002063_abnormal_learning/memory/cond | 1.28682107 |
| 79 | MP0005197_abnormal_uvea_morphology | 1.28490352 |
| 80 | MP0001542_abnormal_bone_strength | 1.28242570 |
| 81 | MP0002752_abnormal_somatic_nervous | 1.28022580 |
| 82 | MP0003690_abnormal_glial_cell | 1.27691971 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 1.26802845 |
| 84 | MP0003632_abnormal_nervous_system | 1.26558432 |
| 85 | MP0000733_abnormal_muscle_development | 1.26034404 |
| 86 | MP0009745_abnormal_behavioral_response | 1.22872141 |
| 87 | MP0009046_muscle_twitch | 1.21823893 |
| 88 | MP0002572_abnormal_emotion/affect_behav | 1.21189361 |
| 89 | MP0001216_abnormal_epidermal_layer | 1.20651954 |
| 90 | MP0000371_diluted_coat_color | 1.19661620 |
| 91 | MP0000579_abnormal_nail_morphology | 1.17879557 |
| 92 | MP0003191_abnormal_cellular_cholesterol | 1.17668337 |
| 93 | MP0005451_abnormal_body_composition | 1.17282752 |
| 94 | MP0005645_abnormal_hypothalamus_physiol | 1.17132617 |
| 95 | MP0001243_abnormal_dermal_layer | 1.17123847 |
| 96 | MP0002108_abnormal_muscle_morphology | 1.16417430 |
| 97 | MP0004381_abnormal_hair_follicle | 1.16364109 |
| 98 | MP0005501_abnormal_skin_physiology | 1.15619902 |
| 99 | MP0006072_abnormal_retinal_apoptosis | 1.14467437 |
| 100 | MP0000026_abnormal_inner_ear | 1.13444669 |
| 101 | MP0000467_abnormal_esophagus_morphology | 1.13093036 |
| 102 | MP0000003_abnormal_adipose_tissue | 1.12525972 |
| 103 | MP0002066_abnormal_motor_capabilities/c | 1.12350116 |
| 104 | MP0003631_nervous_system_phenotype | 1.11160789 |
| 105 | MP0002102_abnormal_ear_morphology | 1.10941997 |
| 106 | MP0009780_abnormal_chondrocyte_physiolo | 1.09280801 |
| 107 | MP0005171_absent_coat_pigmentation | 1.08526567 |
| 108 | MP0003385_abnormal_body_wall | 1.08396136 |
| 109 | MP0005551_abnormal_eye_electrophysiolog | 1.06775091 |
| 110 | MP0000377_abnormal_hair_follicle | 1.06244470 |
| 111 | MP0001502_abnormal_circadian_rhythm | 1.04409367 |
| 112 | MP0010368_abnormal_lymphatic_system | 1.03788595 |
| 113 | MP0003787_abnormal_imprinting | 1.03117370 |
| 114 | MP0008569_lethality_at_weaning | 1.02910361 |
| 115 | MP0001346_abnormal_lacrimal_gland | 1.02891465 |
| 116 | MP0000427_abnormal_hair_cycle | 1.02868378 |
| 117 | MP0002095_abnormal_skin_pigmentation | 1.02444844 |
| 118 | MP0009250_abnormal_appendicular_skeleto | 1.00250885 |
| 119 | MP0005410_abnormal_fertilization | 0.99651485 |
| 120 | MP0000534_abnormal_ureter_morphology | 0.99620643 |
| 121 | MP0003718_maternal_effect | 0.99572767 |
| 122 | MP0003633_abnormal_nervous_system | 0.99374260 |
| 123 | MP0005174_abnormal_tail_pigmentation | 0.99289743 |
| 124 | MP0010678_abnormal_skin_adnexa | 0.99174905 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.98518844 |
| 126 | MP0000767_abnormal_smooth_muscle | 0.98474649 |
| 127 | MP0004924_abnormal_behavior | 0.97289189 |
| 128 | MP0005386_behavior/neurological_phenoty | 0.97289189 |
| 129 | MP0001501_abnormal_sleep_pattern | 0.96319945 |
| 130 | MP0010771_integument_phenotype | 0.95756022 |
| 131 | MP0005360_urolithiasis | 0.94322906 |
| 132 | MP0008789_abnormal_olfactory_epithelium | 0.94190170 |
| 133 | MP0003195_calcinosis | 0.93805306 |
| 134 | MP0003283_abnormal_digestive_organ | 0.93556190 |
| 135 | MP0000538_abnormal_urinary_bladder | 0.93422291 |
| 136 | MP0004084_abnormal_cardiac_muscle | 0.92519944 |
| 137 | MP0001849_ear_inflammation | 0.92203927 |
| 138 | MP0005058_abnormal_lysosome_morphology | 0.92115903 |
| 139 | MP0002282_abnormal_trachea_morphology | 0.91831691 |
| 140 | MP0002177_abnormal_outer_ear | 0.91767188 |
| 141 | MP0003806_abnormal_nucleotide_metabolis | 0.90132456 |
| 142 | MP0001440_abnormal_grooming_behavior | 0.89850869 |
| 143 | MP0001986_abnormal_taste_sensitivity | 0.89771910 |
| 144 | MP0005187_abnormal_penis_morphology | 0.89639033 |
| 145 | MP0002909_abnormal_adrenal_gland | 0.89012775 |
| 146 | MP0003137_abnormal_impulse_conducting | 0.88226648 |
| 147 | MP0002098_abnormal_vibrissa_morphology | 0.86781306 |
| 148 | MP0003091_abnormal_cell_migration | 0.86448759 |
| 149 | MP0005193_abnormal_anterior_eye | 0.85977710 |
| 150 | MP0002233_abnormal_nose_morphology | 0.85924352 |
| 151 | MP0003937_abnormal_limbs/digits/tail_de | 0.83604838 |
| 152 | MP0000604_amyloidosis | 0.83590800 |
| 153 | MP0005620_abnormal_muscle_contractility | 0.83053662 |
| 154 | MP0001186_pigmentation_phenotype | 0.82061224 |
| 155 | MP0004185_abnormal_adipocyte_glucose | 0.81463054 |
| 156 | MP0000762_abnormal_tongue_morphology | 0.81443637 |
| 157 | MP0004811_abnormal_neuron_physiology | 0.79876781 |
| 158 | MP0002557_abnormal_social/conspecific_i | 0.79683366 |
| 159 | MP0002075_abnormal_coat/hair_pigmentati | 0.78317098 |
| 160 | MP0010386_abnormal_urinary_bladder | 0.78258536 |
| 161 | MP0009840_abnormal_foam_cell | 0.77421251 |
| 162 | MP0002938_white_spotting | 0.76987930 |
| 163 | MP0004215_abnormal_myocardial_fiber | 0.76531668 |
| 164 | MP0006138_congestive_heart_failure | 0.76429038 |
| 165 | MP0004858_abnormal_nervous_system | 0.76310301 |
| 166 | MP0005195_abnormal_posterior_eye | 0.75896323 |
| 167 | MP0005330_cardiomyopathy | 0.75624006 |
| 168 | MP0002234_abnormal_pharynx_morphology | 0.75065749 |
| 169 | MP0000759_abnormal_skeletal_muscle | 0.74994051 |
| 170 | MP0002115_abnormal_skeleton_extremities | 0.74825436 |
| 171 | MP0001664_abnormal_digestion | 0.74792232 |
| 172 | MP0002295_abnormal_pulmonary_circulatio | 0.73708363 |
| 173 | MP0003755_abnormal_palate_morphology | 0.72544507 |
| 174 | MP0000432_abnormal_head_morphology | 0.72541934 |
| 175 | MP0000163_abnormal_cartilage_morphology | 0.70022233 |
| 176 | MP0000383_abnormal_hair_follicle | 0.68955312 |
| 177 | MP0004782_abnormal_surfactant_physiolog | 0.68427183 |
| 178 | MP0002009_preneoplasia | 0.68368571 |
| 179 | MP0001879_abnormal_lymphatic_vessel | 0.66643980 |
| 180 | MP0000647_abnormal_sebaceous_gland | 0.66518080 |
| 181 | MP0004233_abnormal_muscle_weight | 0.66080969 |
| 182 | MP0004087_abnormal_muscle_fiber | 0.64869993 |
| 183 | MP0000627_abnormal_mammary_gland | 0.63736631 |
| 184 | MP0002109_abnormal_limb_morphology | 0.63514391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.48114523 |
| 2 | Atrophic scars (HP:0001075) | 5.25514715 |
| 3 | Protrusio acetabuli (HP:0003179) | 4.62707723 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.23476638 |
| 5 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.23476638 |
| 6 | Insidious onset (HP:0003587) | 4.19330402 |
| 7 | Termporal pattern (HP:0011008) | 4.19330402 |
| 8 | Aortic dissection (HP:0002647) | 4.10433316 |
| 9 | Neurofibrillary tangles (HP:0002185) | 3.93270455 |
| 10 | Epiphyseal dysplasia (HP:0002656) | 3.93131391 |
| 11 | Abnormality of nail color (HP:0100643) | 3.91497326 |
| 12 | Vascular tortuosity (HP:0004948) | 3.76351542 |
| 13 | Onycholysis (HP:0001806) | 3.73066366 |
| 14 | Arterial tortuosity (HP:0005116) | 3.71775048 |
| 15 | Hypoplastic ischia (HP:0003175) | 3.67006403 |
| 16 | Alopecia of scalp (HP:0002293) | 3.44631504 |
| 17 | Irregular epiphyses (HP:0010582) | 3.44074299 |
| 18 | Plantar hyperkeratosis (HP:0007556) | 3.36817516 |
| 19 | Abnormality of the ischium (HP:0003174) | 3.33743135 |
| 20 | Abnormality of the corticospinal tract (HP:0002492) | 3.33035457 |
| 21 | Follicular hyperkeratosis (HP:0007502) | 3.31853931 |
| 22 | Pheochromocytoma (HP:0002666) | 3.27644672 |
| 23 | Retinal dysplasia (HP:0007973) | 3.16269241 |
| 24 | Peripheral hypomyelination (HP:0007182) | 3.15166266 |
| 25 | Spondylolisthesis (HP:0003302) | 3.12014332 |
| 26 | Fragile skin (HP:0001030) | 3.11464893 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 3.08241819 |
| 28 | Pterygium (HP:0001059) | 3.01881641 |
| 29 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.99278344 |
| 30 | Soft skin (HP:0000977) | 2.98744500 |
| 31 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.97045961 |
| 32 | Osteolytic defects of the hand bones (HP:0009699) | 2.97045961 |
| 33 | Milia (HP:0001056) | 2.94687835 |
| 34 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.92568902 |
| 35 | Wormian bones (HP:0002645) | 2.92372798 |
| 36 | Myokymia (HP:0002411) | 2.90678051 |
| 37 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.88035492 |
| 38 | Fragile nails (HP:0001808) | 2.85444971 |
| 39 | Onion bulb formation (HP:0003383) | 2.82222102 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 2.81910029 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 2.81747518 |
| 42 | Ankle clonus (HP:0011448) | 2.79789681 |
| 43 | Bladder diverticulum (HP:0000015) | 2.76601260 |
| 44 | Palmoplantar hyperkeratosis (HP:0000972) | 2.74750520 |
| 45 | Aortic aneurysm (HP:0004942) | 2.74648959 |
| 46 | Natal tooth (HP:0000695) | 2.74240339 |
| 47 | Neuroendocrine neoplasm (HP:0100634) | 2.71428133 |
| 48 | Calf muscle hypertrophy (HP:0008981) | 2.70173827 |
| 49 | Palmar hyperkeratosis (HP:0010765) | 2.69501301 |
| 50 | Abnormal auditory evoked potentials (HP:0006958) | 2.66313366 |
| 51 | Vertebral compression fractures (HP:0002953) | 2.65684480 |
| 52 | Muscle fiber splitting (HP:0003555) | 2.64222492 |
| 53 | Coronal craniosynostosis (HP:0004440) | 2.57234136 |
| 54 | Mitral stenosis (HP:0001718) | 2.53892628 |
| 55 | Cerebral hypomyelination (HP:0006808) | 2.48117769 |
| 56 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.47183298 |
| 57 | Alacrima (HP:0000522) | 2.45821365 |
| 58 | Spastic gait (HP:0002064) | 2.44584097 |
| 59 | Delayed epiphyseal ossification (HP:0002663) | 2.42969706 |
| 60 | Abnormality of the umbilical cord (HP:0010881) | 2.42216655 |
| 61 | Thick nail (HP:0001805) | 2.39887608 |
| 62 | Abnormality of dentin (HP:0010299) | 2.39032775 |
| 63 | Enlarged epiphyses (HP:0010580) | 2.38989864 |
| 64 | Hypoplasia of the iris (HP:0007676) | 2.35684876 |
| 65 | Hypokalemic alkalosis (HP:0001949) | 2.35300324 |
| 66 | Popliteal pterygium (HP:0009756) | 2.35233450 |
| 67 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.34770829 |
| 68 | Metabolic alkalosis (HP:0200114) | 2.34606875 |
| 69 | Syringomyelia (HP:0003396) | 2.30873246 |
| 70 | Spinal cord lesions (HP:0100561) | 2.30873246 |
| 71 | Atonic seizures (HP:0010819) | 2.30392462 |
| 72 | Foot dorsiflexor weakness (HP:0009027) | 2.29922364 |
| 73 | Vitreoretinal degeneration (HP:0000655) | 2.28636152 |
| 74 | Elbow flexion contracture (HP:0002987) | 2.28631562 |
| 75 | Type 1 muscle fiber predominance (HP:0003803) | 2.27489899 |
| 76 | Neonatal short-limb short stature (HP:0008921) | 2.24243883 |
| 77 | Abnormality of the acetabulum (HP:0003170) | 2.23786502 |
| 78 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.23659704 |
| 79 | Aplasia of the phalanges of the hand (HP:0009802) | 2.23659704 |
| 80 | Aplasia involving bones of the extremities (HP:0009825) | 2.23659704 |
| 81 | Ankle contracture (HP:0006466) | 2.22004400 |
| 82 | Hammertoe (HP:0001765) | 2.21103061 |
| 83 | Dysmetria (HP:0001310) | 2.16715167 |
| 84 | Ulnar claw (HP:0001178) | 2.16226505 |
| 85 | Scanning speech (HP:0002168) | 2.15488894 |
| 86 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.15220914 |
| 87 | Microglossia (HP:0000171) | 2.14775473 |
| 88 | Small epiphyses (HP:0010585) | 2.14574966 |
| 89 | White forelock (HP:0002211) | 2.14080249 |
| 90 | Limb dystonia (HP:0002451) | 2.13330216 |
| 91 | Nonprogressive disorder (HP:0003680) | 2.13298651 |
| 92 | Thin bony cortex (HP:0002753) | 2.12263926 |
| 93 | Type II lissencephaly (HP:0007260) | 2.11531846 |
| 94 | Cardiovascular calcification (HP:0011915) | 2.10253525 |
| 95 | Patchy hypopigmentation of hair (HP:0011365) | 2.09508184 |
| 96 | Ridged nail (HP:0001807) | 2.07411508 |
| 97 | Calcaneovalgus deformity (HP:0001848) | 2.07329388 |
| 98 | Abnormality of the foot musculature (HP:0001436) | 2.03078999 |
| 99 | Abnormality of the vitreous humor (HP:0004327) | 2.02978513 |
| 100 | Morphological abnormality of the inner ear (HP:0011390) | 2.02502486 |
| 101 | Flat capital femoral epiphysis (HP:0003370) | 2.02159991 |
| 102 | Gowers sign (HP:0003391) | 2.02088902 |
| 103 | Action tremor (HP:0002345) | 2.01695051 |
| 104 | Amniotic constriction ring (HP:0009775) | 2.01694379 |
| 105 | Abnormality of placental membranes (HP:0011409) | 2.01694379 |
| 106 | Cervical subluxation (HP:0003308) | 2.01401416 |
| 107 | Anosmia (HP:0000458) | 2.00914206 |
| 108 | Intention tremor (HP:0002080) | 2.00536478 |
| 109 | Knee flexion contracture (HP:0006380) | 1.99813631 |
| 110 | Mitral valve prolapse (HP:0001634) | 1.99774052 |
| 111 | Abnormal hair laboratory examination (HP:0003328) | 1.99516356 |
| 112 | Pili torti (HP:0003777) | 1.98697224 |
| 113 | Absent eyelashes (HP:0000561) | 1.98348054 |
| 114 | Increased circulating renin level (HP:0000848) | 1.98223034 |
| 115 | Hyporeflexia of lower limbs (HP:0002600) | 1.98101959 |
| 116 | Bell-shaped thorax (HP:0001591) | 1.97626354 |
| 117 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.97574984 |
| 118 | Single umbilical artery (HP:0001195) | 1.97574984 |
| 119 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.97574984 |
| 120 | Advanced eruption of teeth (HP:0006288) | 1.97118305 |
| 121 | Short nail (HP:0001799) | 1.93165287 |
| 122 | Hypotrichosis (HP:0001006) | 1.93083862 |
| 123 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.92949850 |
| 124 | Dilatation of the ascending aorta (HP:0005111) | 1.92743948 |
| 125 | Sensory axonal neuropathy (HP:0003390) | 1.92665218 |
| 126 | Adrenal hypoplasia (HP:0000835) | 1.92590072 |
| 127 | Steppage gait (HP:0003376) | 1.92482286 |
| 128 | Nail dystrophy (HP:0008404) | 1.91812616 |
| 129 | Aplasia cutis congenita (HP:0001057) | 1.89650384 |
| 130 | Chronic bronchitis (HP:0004469) | 1.89020574 |
| 131 | Cerebral hemorrhage (HP:0001342) | 1.88914339 |
| 132 | Overgrowth (HP:0001548) | 1.88724057 |
| 133 | Ovoid vertebral bodies (HP:0003300) | 1.87802545 |
| 134 | Abnormality of glycolysis (HP:0004366) | 1.86798172 |
| 135 | Increased serum pyruvate (HP:0003542) | 1.86798172 |
| 136 | Deformed tarsal bones (HP:0008119) | 1.86325370 |
| 137 | Spinal rigidity (HP:0003306) | 1.85756538 |
| 138 | Ulnar bowing (HP:0003031) | 1.85270926 |
| 139 | Barrel-shaped chest (HP:0001552) | 1.85115093 |
| 140 | Abnormality of macular pigmentation (HP:0008002) | 1.84796167 |
| 141 | Selective tooth agenesis (HP:0001592) | 1.84535679 |
| 142 | Femoral bowing (HP:0002980) | 1.83326438 |
| 143 | Megalencephaly (HP:0001355) | 1.83059472 |
| 144 | Mixed hearing impairment (HP:0000410) | 1.82125710 |
| 145 | Aortic regurgitation (HP:0001659) | 1.80977182 |
| 146 | Male infertility (HP:0003251) | 1.80812464 |
| 147 | Stridor (HP:0010307) | 1.80775718 |
| 148 | Difficulty running (HP:0009046) | 1.78749844 |
| 149 | Abnormal tarsal ossification (HP:0008369) | 1.77653181 |
| 150 | Shallow orbits (HP:0000586) | 1.77453843 |
| 151 | Abnormality of the calf musculature (HP:0001430) | 1.76708812 |
| 152 | Generalized tonic-clonic seizures (HP:0002069) | 1.76458550 |
| 153 | Abnormality of secondary sexual hair (HP:0009888) | 1.75882903 |
| 154 | Abnormality of the axillary hair (HP:0100134) | 1.75882903 |
| 155 | Blue sclerae (HP:0000592) | 1.74888967 |
| 156 | Hallux valgus (HP:0001822) | 1.74317055 |
| 157 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.74153198 |
| 158 | Abnormality of femoral epiphyses (HP:0006499) | 1.73531818 |
| 159 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.73531818 |
| 160 | Lower limb muscle weakness (HP:0007340) | 1.73105919 |
| 161 | Protuberant abdomen (HP:0001538) | 1.72640671 |
| 162 | Generalized hypopigmentation (HP:0007513) | 1.72577235 |
| 163 | Decreased lacrimation (HP:0000633) | 1.72507894 |
| 164 | Deviation of the hallux (HP:0010051) | 1.72344279 |
| 165 | Vaginal atresia (HP:0000148) | 1.70913381 |
| 166 | Abnormal delivery (HP:0001787) | 1.70043055 |
| 167 | Genital tract atresia (HP:0001827) | 1.69886114 |
| 168 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.69568897 |
| 169 | Severe Myopia (HP:0011003) | 1.69355243 |
| 170 | Parakeratosis (HP:0001036) | 1.68786838 |
| 171 | Tibial bowing (HP:0002982) | 1.68583816 |
| 172 | Methylmalonic acidemia (HP:0002912) | 1.67875143 |
| 173 | Absent phalangeal crease (HP:0006109) | 1.67794017 |
| 174 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.67509994 |
| 175 | Autoamputation (HP:0001218) | 1.67158968 |
| 176 | Abnormality of glycolipid metabolism (HP:0010969) | 1.67041284 |
| 177 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.67041284 |
| 178 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.67041284 |
| 179 | Lip pit (HP:0100267) | 1.66538309 |
| 180 | Blue irides (HP:0000635) | 1.66248114 |
| 181 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.66227193 |
| 182 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.65978475 |
| 183 | Hyperextensible skin (HP:0000974) | 1.65621716 |
| 184 | Genu varum (HP:0002970) | 1.65242337 |
| 185 | Genu recurvatum (HP:0002816) | 1.65062162 |
| 186 | Flattened epiphyses (HP:0003071) | 1.65042008 |
| 187 | Round ear (HP:0100830) | 1.64634676 |
| 188 | Hypothermia (HP:0002045) | 1.64550289 |
| 189 | Skin nodule (HP:0200036) | 1.64472307 |
| 190 | Focal motor seizures (HP:0011153) | 1.63991853 |
| 191 | Abnormality of the femoral head (HP:0003368) | 1.63768090 |
| 192 | Leukodystrophy (HP:0002415) | 1.63676380 |
| 193 | Decreased motor nerve conduction velocity (HP:0003431) | 1.63645937 |
| 194 | Cerebellar dysplasia (HP:0007033) | 1.63473108 |
| 195 | Hoarse voice (HP:0001609) | 1.62338868 |
| 196 | Albinism (HP:0001022) | 1.62252352 |
| 197 | Focal seizures (HP:0007359) | 1.61914721 |
| 198 | Delayed gross motor development (HP:0002194) | 1.61595803 |
| 199 | Muscle fiber inclusion bodies (HP:0100299) | 1.61460157 |
| 200 | Absent frontal sinuses (HP:0002688) | 1.61338266 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.74006947 |
| 2 | MAPKAPK5 | 3.24457504 |
| 3 | OXSR1 | 3.16048091 |
| 4 | MUSK | 3.13534116 |
| 5 | MST1R | 3.08348959 |
| 6 | EPHB1 | 2.87845010 |
| 7 | KSR2 | 2.45167036 |
| 8 | WNK4 | 2.42794747 |
| 9 | PDGFRA | 2.42304639 |
| 10 | MAP3K12 | 2.27237698 |
| 11 | SCYL2 | 2.22031573 |
| 12 | MYLK | 2.21965854 |
| 13 | PIM2 | 2.17786430 |
| 14 | EIF2AK3 | 2.09888704 |
| 15 | NTRK1 | 2.03780608 |
| 16 | DDR2 | 2.03073660 |
| 17 | PHKG2 | 1.98650727 |
| 18 | PHKG1 | 1.98650727 |
| 19 | TGFBR2 | 1.95065769 |
| 20 | AKT3 | 1.94501125 |
| 21 | PAK6 | 1.91919696 |
| 22 | MAP3K9 | 1.88272684 |
| 23 | ARAF | 1.87533509 |
| 24 | RIPK1 | 1.84900550 |
| 25 | STK24 | 1.84704438 |
| 26 | NEK1 | 1.80868039 |
| 27 | LIMK1 | 1.79628209 |
| 28 | CSNK1G3 | 1.77395744 |
| 29 | EPHB2 | 1.65554596 |
| 30 | KSR1 | 1.61590423 |
| 31 | PDK2 | 1.58736388 |
| 32 | MAPK15 | 1.56342513 |
| 33 | TTN | 1.54317292 |
| 34 | CSNK1G2 | 1.52908940 |
| 35 | PAK3 | 1.51451152 |
| 36 | PTK2 | 1.50563085 |
| 37 | CSNK1G1 | 1.50510345 |
| 38 | EPHA2 | 1.47874413 |
| 39 | WNK1 | 1.46724842 |
| 40 | PKN1 | 1.45364900 |
| 41 | PAK2 | 1.40994888 |
| 42 | EEF2K | 1.40053324 |
| 43 | LATS2 | 1.37815207 |
| 44 | ERBB4 | 1.36875424 |
| 45 | CAMK2D | 1.36020297 |
| 46 | BMPR2 | 1.34237737 |
| 47 | LMTK2 | 1.33287860 |
| 48 | PINK1 | 1.32884776 |
| 49 | BCR | 1.31604898 |
| 50 | MET | 1.30865488 |
| 51 | TGFBR1 | 1.30015654 |
| 52 | DYRK2 | 1.29244665 |
| 53 | MARK1 | 1.28775470 |
| 54 | SGK223 | 1.28334259 |
| 55 | SGK494 | 1.28334259 |
| 56 | PIK3CG | 1.27551941 |
| 57 | UHMK1 | 1.26924645 |
| 58 | PAK4 | 1.26807136 |
| 59 | CAMK2B | 1.23642188 |
| 60 | EPHA3 | 1.21423846 |
| 61 | MAP3K4 | 1.21089427 |
| 62 | MAP3K2 | 1.20260663 |
| 63 | EIF2AK1 | 1.12106752 |
| 64 | CSNK1A1L | 1.11815423 |
| 65 | SIK1 | 1.08963628 |
| 66 | PIK3CA | 1.08683902 |
| 67 | ERBB3 | 1.06318452 |
| 68 | BRAF | 1.04513199 |
| 69 | TESK1 | 1.02378366 |
| 70 | PRKD3 | 1.02077433 |
| 71 | CAMK2A | 1.01977043 |
| 72 | STK38L | 0.98324596 |
| 73 | CDK19 | 0.96635848 |
| 74 | TYRO3 | 0.95904865 |
| 75 | MOS | 0.95451633 |
| 76 | ROCK2 | 0.95162903 |
| 77 | CAMK2G | 0.94838589 |
| 78 | MARK2 | 0.92279202 |
| 79 | OBSCN | 0.92016890 |
| 80 | CASK | 0.90946085 |
| 81 | HIPK2 | 0.90043698 |
| 82 | STK3 | 0.89251545 |
| 83 | ICK | 0.86848689 |
| 84 | TRPM7 | 0.85040476 |
| 85 | PDGFRB | 0.84658051 |
| 86 | NTRK3 | 0.83847887 |
| 87 | FGFR2 | 0.82499096 |
| 88 | MAPK13 | 0.82005192 |
| 89 | ILK | 0.81451906 |
| 90 | INSRR | 0.81071742 |
| 91 | WEE1 | 0.80661202 |
| 92 | LATS1 | 0.79920093 |
| 93 | PBK | 0.78983262 |
| 94 | RET | 0.76843940 |
| 95 | FGFR3 | 0.75401226 |
| 96 | TAOK3 | 0.75360520 |
| 97 | CDK5 | 0.74334672 |
| 98 | MAP3K6 | 0.74095806 |
| 99 | MST4 | 0.73144256 |
| 100 | GRK5 | 0.72741118 |
| 101 | MAP2K1 | 0.72079332 |
| 102 | CDK6 | 0.72038138 |
| 103 | PLK4 | 0.71452840 |
| 104 | CAMK1G | 0.71241641 |
| 105 | EIF2AK2 | 0.70532780 |
| 106 | ROCK1 | 0.70282310 |
| 107 | AKT2 | 0.70129334 |
| 108 | MAPKAPK3 | 0.69314821 |
| 109 | PRKCE | 0.67662225 |
| 110 | CDK14 | 0.66873679 |
| 111 | PRKD1 | 0.66445923 |
| 112 | PLK2 | 0.66245566 |
| 113 | FGR | 0.65924276 |
| 114 | RAF1 | 0.65097571 |
| 115 | NME1 | 0.64730326 |
| 116 | STK38 | 0.64424996 |
| 117 | ABL2 | 0.63238752 |
| 118 | MAP2K7 | 0.63085885 |
| 119 | NTRK2 | 0.61858708 |
| 120 | STK11 | 0.56856252 |
| 121 | FGFR1 | 0.56274464 |
| 122 | NEK6 | 0.54814915 |
| 123 | MTOR | 0.54738207 |
| 124 | CDK15 | 0.53848222 |
| 125 | PNCK | 0.53653885 |
| 126 | PKN2 | 0.52564023 |
| 127 | PRKG2 | 0.51225978 |
| 128 | GRK7 | 0.51047673 |
| 129 | MINK1 | 0.51041606 |
| 130 | MAP2K4 | 0.50768797 |
| 131 | ERN1 | 0.50261539 |
| 132 | CDK18 | 0.50221438 |
| 133 | TTK | 0.50025738 |
| 134 | MELK | 0.49470399 |
| 135 | MAP3K1 | 0.47818291 |
| 136 | BRD4 | 0.47648130 |
| 137 | CCNB1 | 0.47295466 |
| 138 | MAPK7 | 0.47212411 |
| 139 | RPS6KA2 | 0.46996226 |
| 140 | MAP2K2 | 0.46406483 |
| 141 | RPS6KB1 | 0.45580342 |
| 142 | FLT3 | 0.45168564 |
| 143 | EPHA4 | 0.45058567 |
| 144 | PRKG1 | 0.45041342 |
| 145 | CDK11A | 0.44771050 |
| 146 | DMPK | 0.44733586 |
| 147 | GSK3A | 0.43944390 |
| 148 | FRK | 0.42796110 |
| 149 | CDK12 | 0.40672656 |
| 150 | JAK1 | 0.39006663 |
| 151 | MAP3K13 | 0.38170509 |
| 152 | FER | 0.38122476 |
| 153 | PRKACA | 0.36375363 |
| 154 | ABL1 | 0.35827342 |
| 155 | NEK9 | 0.35804965 |
| 156 | DAPK3 | 0.34304666 |
| 157 | MAP3K5 | 0.32971051 |
| 158 | PDPK1 | 0.32772658 |
| 159 | CSNK1A1 | 0.31578264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.64595248 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.91182177 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.69623987 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.63015047 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.45980842 |
| 6 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.35258758 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.29072031 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.22528907 |
| 9 | Focal adhesion_Homo sapiens_hsa04510 | 2.12190479 |
| 10 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.97932114 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.88799319 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.88465463 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81232752 |
| 14 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.75937964 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.74182166 |
| 16 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.73204866 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.71489099 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67581197 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.66221101 |
| 20 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.65235656 |
| 21 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.64808647 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.63094547 |
| 23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.61869746 |
| 24 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.60911524 |
| 25 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.60266609 |
| 26 | Adherens junction_Homo sapiens_hsa04520 | 1.59010696 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56280822 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.49956868 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.49266677 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.48872823 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.47953924 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.44931375 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.44773410 |
| 34 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.43287618 |
| 35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.41537018 |
| 36 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.41275395 |
| 37 | Amoebiasis_Homo sapiens_hsa05146 | 1.39505893 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.39401438 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.39047394 |
| 40 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.38776642 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 1.36762156 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 1.34746745 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.33563758 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 1.32534361 |
| 45 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30125060 |
| 46 | Bladder cancer_Homo sapiens_hsa05219 | 1.28377383 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.27144586 |
| 48 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26637604 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.24557461 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.24533528 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 1.23343011 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 1.21470828 |
| 53 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.21433044 |
| 54 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19885383 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19383873 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.15741190 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 1.15727054 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.15575996 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.13844173 |
| 60 | Morphine addiction_Homo sapiens_hsa05032 | 1.11666327 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.11380756 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11175853 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10744969 |
| 64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.10725346 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10533598 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.10473078 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04125396 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 1.00830649 |
| 69 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99746801 |
| 70 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98900930 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98342892 |
| 72 | Melanoma_Homo sapiens_hsa05218 | 0.97074371 |
| 73 | Prostate cancer_Homo sapiens_hsa05215 | 0.96648074 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95359218 |
| 75 | Gap junction_Homo sapiens_hsa04540 | 0.94126468 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.93812612 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93744036 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.93594508 |
| 79 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92646100 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92435521 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.91905035 |
| 82 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.91484492 |
| 83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91411930 |
| 84 | Nicotine addiction_Homo sapiens_hsa05033 | 0.91382984 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90323334 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90067308 |
| 87 | Tight junction_Homo sapiens_hsa04530 | 0.89448537 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.88448972 |
| 89 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88267545 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86973623 |
| 91 | Phototransduction_Homo sapiens_hsa04744 | 0.86939979 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86221084 |
| 93 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.84354715 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.83140130 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81675252 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.80841450 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80507233 |
| 98 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80433426 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80225108 |
| 100 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79653944 |
| 101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78764050 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.77802108 |
| 103 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.77161265 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76814664 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76659105 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76551064 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75603715 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75455290 |
| 109 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74946161 |
| 110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74462099 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.74228123 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72698012 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72496428 |
| 114 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72434452 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71914136 |
| 116 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71816860 |
| 117 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71072790 |
| 118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.70181275 |
| 119 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69867608 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69591503 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69156087 |
| 122 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67924065 |
| 123 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.67769920 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67508982 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65811164 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64541323 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64185581 |
| 128 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63488535 |
| 129 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63026542 |
| 130 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.61431719 |
| 131 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61429791 |
| 132 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61391616 |
| 133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60598515 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60355921 |
| 135 | Huntingtons disease_Homo sapiens_hsa05016 | 0.59959256 |
| 136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59732286 |
| 137 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.59684161 |
| 138 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58766548 |
| 139 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57990795 |
| 140 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57825730 |
| 141 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57090041 |
| 142 | Melanogenesis_Homo sapiens_hsa04916 | 0.56262655 |
| 143 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55379761 |
| 144 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54674263 |
| 145 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.54080834 |
| 146 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53625246 |
| 147 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52188494 |
| 148 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51997919 |
| 149 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51472067 |
| 150 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51307520 |
| 151 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50999867 |
| 152 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50892428 |
| 153 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50601969 |
| 154 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49668170 |
| 155 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49555533 |
| 156 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47937537 |
| 157 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47886932 |
| 158 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.47069148 |
| 159 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46830399 |
| 160 | Insulin resistance_Homo sapiens_hsa04931 | 0.44959445 |
| 161 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44868607 |
| 162 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44648457 |
| 163 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43121999 |
| 164 | Endocytosis_Homo sapiens_hsa04144 | 0.41927863 |
| 165 | Bile secretion_Homo sapiens_hsa04976 | 0.41737374 |
| 166 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40103728 |
| 167 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38408429 |

